Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-013699
Filing Date
2017-03-09
Accepted
2017-03-09 16:14:26
Documents
3
Period of Report
2017-03-09

Document Format Files

Seq Description Document Type Size
1 6-K v461517_6k.htm 6-K 17760
2 EXHIBIT 10.1 v461517_ex10-1.htm EX-10.1 202972
3 EXHIBIT 10.2 v461517_ex10-2.htm EX-10.2 109774
  Complete submission text file 0001144204-17-013699.txt   331512
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 17678439
SIC: 2834 Pharmaceutical Preparations